Kovai Medical Center & Hospital enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY20Mar 2020
6,452—
508508
6,879—
₹6,286.65—
939939
54.1%54.1%
0.07×—
9.67×—
40.93×—
59.33×—
41.40×—
Reference items — trailing FY values
712712
168168
116116
166166
−102−102
−104−104
268268
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KOVAI₹5,896.00

Kovai Medical Center & Hospital Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKMCSHILLOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹6,452 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY20
31/03/2020
Current
last close
Market Capitalization—6,451.7
+ Total Debt508.4508.4
Enterprise Value—6,879.2
EV per Share—6,286.65
Total Capital939.4939.4
Total Debt/Total Capital54.1254.12
Total Debt/EV—0.07
EV/Sales—9.67
EV/EBITDA—40.93
EV/EBIT—59.33
EV/Operating Cash Flow—41.40
Reference Items — Trailing FY Values
Sales711.7711.7
EBITDA168.1168.1
EBIT115.9115.9
Operating Cash Flow166.2166.2
Free Cash Flow-101.9-101.9
FCFF (free cash flow to the firm)-104.0-104.0
Capital Expenditure268.0268.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY20 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.